BMI View: As we anticipated, Jordanian pharmaceutical exports increased in 2012 due to base effects around the Arab Spring in 2011. We project exports from Jordan will slow through to 2017 as generic competition from Indian and Chinese drugmakers increases, and as multinationals address high noncommunicable disease burdens in key GCC markets. To counter these factors, we believe Jordanian drugmakers will widen their presence in Africa by driving volume sales in markets with large populations, such as Nigeria and Egypt. While the country boasts a thriving generic drugs industry with a positive trade balance, it will continue to rely on …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103187.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/jordan-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.
No comments:
Post a Comment